Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
---|
06/03/1999 | WO1999027075A1 A carboxy-terminal brca1 interacting protein |
06/03/1999 | WO1999027020A1 Dibenzorhodamine dyes useful as flourescent labelling agents |
06/03/1999 | WO1999026978A1 Signal sequence trapping method |
06/03/1999 | WO1999026970A1 NOVEL pth |
06/03/1999 | WO1999026961A1 Secreted proteins and polynucleotides encoding them |
06/03/1999 | WO1999026959A1 NOVEL recJ |
06/03/1999 | WO1999026956A1 A combinatorial library of moenomycin analogs and methods of producing same |
06/03/1999 | WO1999026724A2 Devices and methods for detecting target molecules in biological samples |
06/03/1999 | WO1999026664A1 Recombinant mycoplasma hyopneumoniae vaccine |
06/03/1999 | WO1999026475A1 ribG |
06/03/1999 | WO1999015656A3 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
06/03/1999 | WO1999014336A3 Thermostable luciferases and methods of production |
06/03/1999 | WO1999014242A3 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
06/03/1999 | WO1999010535A9 A process to study changes in gene expression in stem cells |
06/03/1999 | WO1999009199A3 Elongation factor-2 kinase (ef-2 kinase) and methods of use therefor |
06/03/1999 | WO1999009166A3 Prostate tumor polynucleotide and antigen compositions |
06/03/1999 | WO1999007885A9 The use of primers for universal fingerprint analysis |
06/03/1999 | WO1999006552B1 5' ESTs FOR SECRETED PROTEINS EXPRESSED IN BRAIN |
06/03/1999 | WO1999006551B1 5' ESTs FOR SECRETED PROTEINS IDENTIFIED FROM BRAIN TISSUES |
06/03/1999 | WO1999006550B1 5' ESTs FOR SECRETED PROTEINS EXPRESSED IN PROSTATE |
06/03/1999 | WO1999006548B1 5'ESTs FOR NON TISSUE SPECIFIC SECRETED PROTEINS |
06/03/1999 | WO1999006422A3 Base analogues |
06/03/1999 | WO1998057746A3 Differential vacuum chamber for directed transport of a substance |
06/03/1999 | CA2311759A1 Recombinant mycoplasma hyopneumoniae vaccine |
06/03/1999 | CA2311683A1 Secreted proteins and polynucleotides encoding them |
06/03/1999 | CA2311632A1 Method and compositions useful for the activation of silent transgenes |
06/03/1999 | CA2311501A1 Devices and methods for detecting target molecules in biological samples |
06/03/1999 | CA2311472A1 Desaturase genes and their use |
06/03/1999 | CA2311164A1 Nucleic acid ligands of tissue target |
06/03/1999 | CA2310808A1 Method of parallel screening for insertion mutants and a kit to perform this method |
06/03/1999 | CA2310621A1 Methods for identifying the toxic/pathologic effect of environmental stimuli on gene transcription |
06/03/1999 | CA2310565A1 Human protein kinase and kinase inhibitors |
06/03/1999 | CA2310561A1 Virulence-associated nucleic acid sequences and uses thereof |
06/03/1999 | CA2310540A1 Human cdc10 homolog |
06/03/1999 | CA2309897A1 A novel egf motif protein obtained from a cdna library of fetal liver-spleen |
06/03/1999 | CA2309888A1 Decreasing cell proliferation by decreasing levels of pp5 |
06/03/1999 | CA2309358A1 A-33 related antigens and their pharmacological uses |
06/03/1999 | CA2307846A1 Chlamydia pneumoniae genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection |
06/03/1999 | CA2223368A1 Polymorphisms in a microsatellite region of a glucocorticoid receptor gene |
06/02/1999 | EP0919633A2 Detection of Neisseria Gonorrhoeae by amplification and detection of its nucleic acid |
06/02/1999 | EP0919632A2 Method for the determination of glycosylated proteins |
06/02/1999 | EP0919631A1 Process for the identification of nucleic acids |
06/02/1999 | EP0919619A2 Optimizing cells for endogenous gene activation |
06/02/1999 | EP0919568A1 Escape mutant of the surface antigen of hepatitis B virus |
06/02/1999 | EP0919565A2 Labeled oligonucleotides |
06/02/1999 | EP0918885A1 Nanoparticles having oligonucleotides attached thereto and uses therefor |
06/02/1999 | EP0918884A1 Prostate cancer drug screening |
06/02/1999 | EP0918883A2 Homogeneous diagnostic assay method utilizing simultaneous target and signal amplification |
06/02/1999 | EP0918882A1 Regulation of apoptosis and in vitro model for studies thereof |
06/02/1999 | EP0918881A1 Dry reagent test strip comprising benzidine dye precursor and antipyrine compound |
06/02/1999 | EP0918880A1 Article and method for detection of enterotoxigenic staphylococci |
06/02/1999 | EP0918871A2 Afc1 and rce1:isoprenylated caax processing enzymes |
06/02/1999 | EP0918867A2 Substrate trapping protein tyrosine phosphatases |
06/02/1999 | EP0918862A2 G protein signal transduction in plants |
06/02/1999 | EP0918857A1 Human induced tumor protein |
06/02/1999 | EP0918855A1 Polycystic kidney disease gene |
06/02/1999 | EP0918854A1 $i(M. TUBERCULOSIS) COMPLEX MEMBERS MYCOBACTERIA SPECIFIC NUCLEIC ACID FRAGMENTS AND THEIR APPLICATIONS FOR THE DETECTION AND DIFFERENTIAL DIAGNOSIS OF $i(M. TUBERCULOSIS) COMPLEX MEMBERS |
06/02/1999 | EP0918852A1 Probe for analysis of nucleic acids |
06/02/1999 | EP0918848A1 Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with rna |
06/02/1999 | EP0918845A1 Cleavable signal element device and method |
06/02/1999 | EP0918796A1 Monoclonal antibody which agglutinates e. coli having the cs4-cfa/i family protein |
06/02/1999 | EP0918788A1 Brca1 compositions and methods for the diagnosis and treatment of breast cancer |
06/02/1999 | EP0918787A1 Compositions and methods for antisense inhibition of protein translation |
06/02/1999 | EP0918786A1 Nuclease protection assays |
06/02/1999 | EP0795031A4 Sequential delivery of purified biological and chemical reagents |
06/02/1999 | EP0646124B1 A genetically engineered cell line for detecting infectious herpes simplex virus and method therefor |
06/02/1999 | DE19752922A1 Measuring apoptosis in mammalian cells |
06/02/1999 | DE19752700A1 1-Deoxy-D-xylulose-5-phosphate synthase protein and modulators |
06/02/1999 | DE19751706A1 Registering the presence of substances for analysis |
06/02/1999 | CN1218553A Method for detection of contaminants |
06/02/1999 | CN1218515A Use of mutation in gene for human G-protein 'beta' 3 sub-unit for diagnosing illnesses |
06/02/1999 | CA2223075A1 Drug binding protein |
06/02/1999 | CA2220785A1 Selective technique for rapid identification of proteins and genes and uses thereof |
06/01/1999 | US5908978 Methods for within family selection of disease resistance in woody perennials using genetic markers |
06/01/1999 | US5908924 Cloning and expression of the gene encoding thermoanaerobacter ethanolicus 39E secondary-alcohol dehydrogenase and enzyme biochemical characterization |
06/01/1999 | US5908920 Cell cycle regulatory gene |
06/01/1999 | US5908845 Polyether nucleic acids |
06/01/1999 | US5908839 Administering mixture of tyrosine kinase inhibitor and amino sterol |
06/01/1999 | US5908778 Mage-10 encoding cDNA, the tumor rejection antigen precursor mage-10, antibodies specific to the molecule, and uses thereof |
06/01/1999 | US5908759 Culturing tree (taxus) fragments on agar until fungal growth occurs, culturing hyphae, grinding mycelium, adding solvent, performing chromatography, spraying with vanillin-sulfuric acid and comparing to standards |
06/01/1999 | US5908758 Isolating microorganisms from soil and screening the samples to identify which isolates contain a nucleotide sequence; classification of microorganisms from the tropical rain forest |
06/01/1999 | US5908756 Protein inhibitor of neuronal nitric oxide synthase |
06/01/1999 | US5908755 Complexing single-stranded polynucleotide with primer |
06/01/1999 | US5908754 Removing disialylated erythropoietin by incubating sample with cells expressing surface asialoglycoprotein receptors, incubating treated portion with responsive cells, comparing activity of treated versus untreated sample |
06/01/1999 | US5908752 Methods for producing phospholipid metabolites in yeast |
06/01/1999 | US5908751 Centrifuging sample, adding buffer with protease-free soluble albumin protein and adenosine triphosphate hydrolase to pellet, incubating at ph 6.0 to 8.0, extracting adenosine triphosphate from cells, analyzing using bioluminescence |
06/01/1999 | US5908750 Screening assays for identifying agents that regulate the expression of genes involved in cell death |
06/01/1999 | US5908749 Human leukocyte antigen characterization using multiallelic microsatellite markers of class ii; sampling dna from individuals and determining allele length; diagnosis, tissue and organ transplantation, autoimmune diseases |
06/01/1999 | US5908745 Exclusion of polymeric beads, enzymes, surfactants and hydrogen peroxide to reduce likeliness of damage to contact lenses or eyes |
06/01/1999 | US5908744 Detecting Mycobacterium tuberculosis by nucleic acid sequence amplification |
06/01/1999 | US5908743 Gag gene primers for the detection of HIV-1 |
06/01/1999 | US5908609 Screening methods for compounds useful in the regulation of body weight |
06/01/1999 | CA2255325A1 Aldehyde oxidase inhibitors for treatment of aids |
06/01/1999 | CA2251260A1 Escape mutant of the surface antigen of hepatitis b virus |
06/01/1999 | CA2227402A1 Cyp2a6 diagnostic methods and treatments |
06/01/1999 | CA2223216A1 Method for identifying agonists and antagonists of dna replication using an in vitro mammalian dna replication system |
06/01/1999 | CA2097698C Human dopamine d4 receptor and its uses |
06/01/1999 | CA2060372C Strand displacement amplification |
06/01/1999 | CA1340574C Method and compositions providing enhanced chemiluminescence from 1,2-dioxetanes |
05/28/1999 | CA2228170A1 1-deoxy-d-xylulose 5-phosphate synthase, a process for identifying effectors of 1-deoxy-d-xylulose 5-phosphate synthase and effectors of 1-deoxy-d-xylulose 5-phosphate synthase |